Related Experiment Video
Updated: Jun 24, 2026

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
Differences in retinal neovascular tissue and vitreous humour in patients with type 1 and type 2 diabetes
K Kinnunen1, T Puustjärvi, M Teräsvirta
1Department of Ophthalmology, Kuopio University Hospital, Kuopio, Finland.
Aims:
The aim of the study was to evaluate the histopathology of neovascular tufts and vitreous samples collected from patients with diabetes.
Methods:
Vitreous samples and neovascular tufts were collected from patients with type 1 (n = 13) and (n = 17) type 2 diabetes with proliferative retinopathy, and from controls with a macular hole (n = 5). Neovessels were analysed using immunohistochemistry and vitreous samples with an enzyme-linked immunosorbent assay (ELISA). The main outcome measure was to examine differences in the levels of growth factors in patients with type 1 and type 2 diabetes with proliferative retinopathy.
Results:
Vascular endothelial growth factor (VEGF)-A was most strongly present in the samples from patients with type 1 diabetes. In type 2 diabetes, VEGF-D was more abundantly present than in type 1 diabetes. Angiopoietin (ANG)-2 was also abundantly present. Macrophages and nuclear factor kappa B (NFkappaB) were found, indicating the presence of an inflammatory process in the neovascular tissues.
Conclusions:
VEGF-A and ANG-2 are equally important in the neovascular process in both type 1 and type 2 diabetes. VEGF-D is abundantly present in type 2 diabetes. In order to achieve better control of diabetic retinopathy, it might be beneficial to develop treatments that prevent the actions of ANG-2 and VEGF-D.
Related Concept Videos
Diabetic Retinopathy
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type I Diabetes III: Clinical Manifestations

